BCR-ABL
Diagnoses chronic myeloid leukaemia and measures response to treatment.
Also known as: BCR ABL, Philadelphia chromosome, CML monitoring
Price on request
We can collect this sample at your home, free of charge. Book a home visit.
- Turnaround
- 10–14 working days
- Preparation
- No fasting needed. Eat and drink normally.
- Sample
- Blood sample
Questions about this test? Message us
About this test
The BCR-ABL fusion gene defines CML and is the target of the drugs used to treat it. Quantitative monitoring on the international scale is how response is judged over years, with the depth of reduction determining whether treatment is working or needs changing.
What it measures
- Qualitative BCR-ABL detection
- Quantitative transcript level, international scale
A note on results. A single test is one part of a clinical picture, not a diagnosis. Discuss your report with a qualified doctor, who will read it alongside your history and examination.
Related to
- Cancer screening
Often ordered with this
AFP (Alpha-Fetoprotein)
A liver and germ-cell tumour marker, also used in antenatal screening.
- 24–48 hours
- No fasting
- Home collection
Beta-2 Microglobulin
Used to stage myeloma and lymphoma, and to assess kidney handling.
- 3–5 working days
- No fasting
- Home collection
Bone Marrow Aspiration & Trephine Biopsy
Samples the blood-forming marrow itself, for leukaemia, lymphoma and unexplained marrow failure.
- 5–7 working days
- No fasting